Thinking about cancer or dealing with cancer risk can be scary or overwhelming, but we believe that receiving information and resources is comforting, empowering, and lifesaving.
Knowing your BRCA status is increasingly important when making treatment decisions, because BRCA-associated cancers may respond better to certain chemotherapies, including a chemotherapy regimen that includes platinum. Oxaliplatin is a platinum-containing drug used in some pancreatic cancer regimens.
Knowing if you have a mutation in BRCA1 or BRCA2 can affect the decision to use oxaliplatin or other platinum drug in the initial chemotherapy to treat your pancreatic cancer. Some clinical trials are using PARP inhibitors to treat pancreatic cancer patients with mutations in BRCA1/2.